ClinVar Miner

Submissions for variant NM_021971.2(GMPPB):c.1070G>A (p.Arg357His)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000705475 SCV000834474 likely pathogenic Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14; Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 2018-07-05 criteria provided, single submitter clinical testing This sequence change replaces arginine with histidine at codon 357 of the GMPPB protein (p.Arg357His). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs771861177, ExAC 0.03%). This variant has been reported to segregate with limb girdle muscular dystrophy/congenital myasthenic syndrome in a family (PMID: 28433477) and has been reported in several additional affected individuals (PMID: 28433477). Experimental studies have shown that this missense change results in increased protein aggregation in vitro (PMID: 28433477). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.